Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Criteria Out For EMA’s Future Home; Bid Procedure About To Be Approved

Executive Summary

The procedure allowing EU member states to bid to host the European Medicines Agency when it leaves the UK is to be formally endorsed by a meeting of heads of state on June 22. The criteria countries will have to meet have been publicly announced at a press conference following a meeting of EU ministers.

You may also be interested in...



Midsummer Madness: EMA Headquarters Rumors Fly At BIO

The biotech industry's annual confab, already known as a stage for countries and regions to play up their potential as industry hubs, is now the venue for rumors over who will host the headquarters for the European Medicines Agency post-Brexit.

July Deadline For EMA Relocation Bids; Member States Begin Scrutiny Of Proposed Hosting Criteria

The criteria that candidates seeking to host the European Medicines Agency post-Brexit will have to meet are out for discussion among member state representatives and should be finalized towards the end of June. Formal bids will have to be in by July end and a decision on the EMA’s new home should be made in October.

Denmark Planning To Impose Drug Stockpiling Obligations From July

A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS120917

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel